NCT01458704
Unknown
Not Applicable
Cancer Genome Analysis
ConditionsMalignant Tumor
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Malignant Tumor
- Sponsor
- Seoul National University Hospital
- Enrollment
- 100
- Locations
- 1
- Primary Endpoint
- targeted sequencing of cancer-relate genes
- Last Updated
- 14 years ago
Overview
Brief Summary
Next generation sequencing (including targeted gene seqeuncing, exome and transcriptome sequencing) will be performed from fresh frozen tumor samples to understand the genetic alteration of tumors and to aid in optimal selection of further therapeutic agents.
Investigators
Eligibility Criteria
Inclusion Criteria
- •patients with malignant tumor
- •receiving or planning to receive chemotherapy
- •with fresh frozen tumor tissue
- •with informed consent
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
targeted sequencing of cancer-relate genes
Time Frame: 1 year
Identification and characterization of genetic alteration in cancer tissue
Study Sites (1)
Loading locations...
Similar Trials
Recruiting
Not Applicable
Potential Clinical Utilities of Circulating Tumor DNA in Advanced HER2 Negative Gastric CancerGastric CancerCirculating Tumor DNA (ctDNA)NCT05513144chenwu30
Recruiting
Not Applicable
Whole Genome Sequencing i n advanced cancer cohort with clinical targeted sequencingKCT0007707Ajou University Hospital60
Recruiting
Not Applicable
Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology PatientsSolid, Liquid, Central Nervous System TumorsNCT02530658St. Jude Children's Research Hospital2,500
Recruiting
Not Applicable
Exploring Cancer Evolution, Prognostic and Predictive Biomarkers in EGFR-mutant NSCLCNon-small Cell Lung CancerNCT05997719Sun Yat-sen University150
Recruiting
Not Applicable
Whole Genome Sequencing (comprehensive entire genome analysis) in Solid CancerNeoplasmsKCT0008118Genome Insight120